Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

RVMD - Revolution Medicines, Inc. Financial... | Finranks

Home

/

RVMD

R

Revolution Medicines, Inc. (RVMD)

NMS – Real Time Price. Currency in USD

207.29

+1.74 (0.84%)

Market open: Aug 12, 2026, 10:14 AM EDT

205.70

+0.15 (0.07%)

Previous after-hours: Aug 11, 2026, 7:58 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

12M

35M

Cost of goods sold

-17M

-12M

-9M

-10M

Gross Profit

-17M

-12M

2M

26M

Operating expenses (excl. COGS)

-1.17B

-678M

-489M

-284M

Operating Income

-1.18B

-690M

-487M

-258M

Non-operating income, total

51M

89M

47M

9M

Pretax income

-1.13B

-601M

-440M

-249M

Equity in earnings

0

0

0

0

Taxes

0

753K

4M

420K

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-1.13B

-600M

-436M

-249M

Discontinued operations

0

0

0

0

Net income

-1.13B

-600M

-436M

-249M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

2.41B-7.5%

2.60B+24.6%

2.09B+149.2%

838M

Total current assets

2.08B

2.33B

1.88B

660M

Total non-current assets

333M

276M

209M

178M

Total liabilities

777M+129.8%

338M+28.9%

262M+71.5%

153M

Total current liabilities

290M

164M

144M

62M

Total non-current liabilities

487M

174M

119M

91M

Total equity

1.63B

2.27B

1.83B

685M

Total liabilities & shareholders' equities

2.41B

2.60B

2.09B

838M

Total debt

427M+214.4%

136M+54.5%

88M+37.0%

64M

Name

2025

2024

2023

2022

Cash from operating activities

-898M

-557M

-351M

-224M

Cash from investing activities

118M

-554M

-343M

-24M

Cash from financing activities

622M

959M

1.23B

301M

Free cash flow

-914M-60.9%

-568M-58.5%

-358M-52.3%

-235M